GlobeNewswire Inc.··DelveinsightComplement Inhibitors Market Set for Robust Growth Through 2036 as C5, C3 Therapies Expand
Complement inhibitors market projected for strong growth through 2036, driven by rising disease prevalence and C5/C3-targeted drug approvals across multiple indications.
NVSSNYRHHBYAZNREGN+3clinical trialsmarket growth